chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A couple days after the vaccine light headedness was experienced. In addition there is feeling of faintness and high blood pressure and head spinning. Over the course of time it has gotten worse.
Tingling in feet, pain in calf muscles. Continued into next morning. Called family doctor who advised me to go to ER.
My menstral cycle started 7 days early which was 6 days after the 2nd dose. It was large clumps not a normal flow for a week then my regular period came. In total My menstral cycle lasted 10 days and is normally 4. Im still spotting and it has been 2weeks 3 days since shot.
Severe shivering and cold feeling .  Could not feel warm even with fleece jacket and several blankets.   Shivering continued from 8 pm on 8/19/2019 until noon on 8/20/2019.   Took ibuprofen stayed in bed with blankets.
I got warm and felt relaxed, almost tired. My arm muscles hurt at the injection site. Around 5am or a bit earlier on 4/24/2021, my whole body?s muscles began to ache. This only got worse as the day wore on. It was so severe it was hurting just sitting and doing nothing. Tylenol relieved the pain around 4pm. My arm at the injection site was only sore for another day or so.
COVID arm?large oval arms at injection site with swelling itching including nerves endings, feverish.  Lasted 2 days. Redness lasted 12 days
Starting 11 days later (December 27), experienced intense itching in armpits and groin on both sides of body. Within hours, developed large raised areas of hives that persist for days. Additional hive outbreaks appear daily, always bilateral in different areas of body (shoulders, armpits, hips, calves, feet, inner elbows, etc.). Occasional low-grade fever. One incident of Angioedema (lip swelling).  After 3 days on high dosage over-the-counter antihistamines (Zyrtec, Pepcid AC, Benadryl) with no relief, started 6-day Prednisone course. Prednisone removed hives within 12 hours of first dose, but hives gradually returned over the course and were fully present again at its end. Symptoms still unresolved after 7 days.
54 hours after injection SEVERE joint pains (including to touch) lasting overnight; This is a spontaneous report from a contactable nurse (patient). A 67-year-old non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), intramuscular in the right arm in Dec2020 04:30 PM at a single dose for COVID-19 immunization at the hospital. Medical history included gastric distress from cow milk products, and allergies to statins, dust/ dust mites. Concomitant medications included loratadine, boswellia serrata (BOSWELLIA), famotidine (PEPCID), and vitamin C. The patient did not received other vaccine within four weeks of COVID vaccine. The patient previously took ciprofloxacin (CIPRO) and experienced allergies. The patient has not been diagnosed of COVID prior vaccination and has not been tested for COVID post vaccination. It was reported that on 23Dec2020 20:00, 54 hours after injection, the patient had severe joint pains (including to touch) lasting overnight. The event was partially improved with Tylenol, loratadine, Benadryl, boswellia; and subsided next day. Outcome of the event was reported as recovering. The event was assessed as non-serious.
Swelling and warmth around site of injection. Swelling extended down to knee. Right thigh only.
Swollen axillary lymph node on injection side.  Heavy, longer menstrual cycle lasting 8 days. Exam by primary with follow up 4 weeks later.  Lymph node larger and more tender at follow up.
This case was reported by a consumer via call center representative and described the occurrence of influenza in a 71-year-old female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included diabetes. On 16th July 2018, the patient received SHINGRIX (intramuscular) .5 ml. On 16th July 2018, less than a day after receiving SHINGRIX, the patient experienced influenza, headache, pain in arm, sweating and shivering. On 17th July 2018, the patient experienced muscle pain. On 18th July 2018, the outcome of the sweating and shivering were recovered/resolved. On an unknown date, the outcome of the influenza was unknown and the outcome of the headache, muscle pain and pain in arm were not recovered/not resolved. It was unknown if the reporter considered the influenza, headache, muscle pain, pain in arm, sweating and shivering to be related to SHINGRIX. Additional details were provided as follows: About 11:00 pm on the day of vaccination, the patient developed a headache. She then broke out in a sweat and started to shiver. The patient's arm became sore about 4 hours after the vaccination. The patient woke up this morning (1 day after receiving vaccination) with a severe headache and muscles ache through her body. The patient compared it to the flu.
The patient experienced a Syncopal episode while he was receiving the listed immunizations. He was sitting in a chair prior to the event due to a severe fear of needles. He stated his head felt heavy and then he passed out, an Ammonia Inhalant was used and he regained consciousness. He did become "extremely" light headed after he regained consciousness but did not pass out again.  There was no physical injury during this episode.
It was pretty severe, I had a nonstop cough, fever, chills, body ache, tired, fatigue. When I met with the doctor he put me on PAXLOVID and within 2 days I was clear of the symptoms. I had been on a cruise and pretty sure I caught it on there.
Diffuse bulbous rash 3 days following vaccination pruritic, on face, trunk, and extremities. Bullous designating surrounding by circular erythema. H/O severe eczema. To ER as no urgent Derm apprs.  9/7 rash improving. Referred to Derm as urgent. ROI sent pending.
Injection site was little sore; This is a spontaneous report from a contactable consumer (patient). An 89-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EJ1686), via an unspecified route of administration on 09Jan2021at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the injection site was little sore on an unspecified date. The patient did not receive treatment for the event reported. The patient underwent lab tests and procedures which included blood test: everything was fine on an unspecified date. Outcome of event was unknown.
Raised welts across head, neck, front and back of torso, shoulders and stomach and wrists. Extreme itching. No treatment.
Information has been received from a consumer concerning her 16 year old daughter with no medical history and an allergy to sulfa medications who on 17-May-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast) (no lot number provided). On 20-JUN-2008 the patient received the second 0.5 ml dose of GARDASIL vaccine (yeast) (no lot number provided). Other therapy included "SYMBIAX". Since receiving the second dose on 20-JUN-2008 she has had a fever and was extremely tired. The patient's fever and extremely tired persisted. Laboratory diagnostics studies performed reported as "lab." At time of reporting patient had not recovered. Unknown medical attention was sought. Additional information has been requested.
swelling & itching in the rt arm;red p/inj & some itching;swelling worsening w/time;
Approximately one hour post vax the pt's hand became swollen and tingly. The pain and swelling has occurred intermittently for one month.
Dr. saw patient on 2/21/208 for her annual wellness visit and was administered a pneumococcal vaccine in her left deltoid. That same day the patient call back to report redness and significant soreness. Patient was advised to use a warm moist compress and to move the shoulder around to improve absorption of the fluid. Patient then underwent surgery by Dr. on the following day for a total knee replacement. Patient followed up on 2/28 with Dr.'s assistant, PA-C. He accessed her surgical site for infection as the patient was reporting fevers. He then referred her back to Dr. to access for infection of the shoulder related to injection. Dr. examined patient the same day. He consulted with PA-C and they both agreed the area should be imaged with ultrasound and determined whether it needed aspiration for evaluation. The patient was sent to the emergency room of Medical Center. At the ED, the fluid in the patients shoulder (bursa) was collected. The radiologist believed it was infected by appearance and the patient was started on a course of Vancomycin. The patient was admitted to hospital. The patient was in hospital until today 3/5/2018.
Fever 104 degrees, oral the evening after (same noc) as receiving immunization. Vomiting and shaking the morning after receiving vaccines.
Headache, muscle aches, blurred vision, skin sensitivity, diarrhea, dizziness, for 11 days post-injection.  Not accompanied by fever.  Negative for strep, negative for COVID via Abbott BinaxNow test, and PCR test administered by urgent care.
Hives; Itchiness; Big bumps; Sore arm; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: FC3180), via an unspecified route of administration, administered in left arm on 11Aug2021 09:30 (at the age of 30-year-old), as dose 1, single for COVID-19 immunisation.  Medical history included mild asthma from an unknown date. Patient had known allergies to shellfish and pineapples. Concomitant medications were reported as none. Prior vaccination, patient was diagnosed with COVID and reported as patient had no other vaccine in four week. The patient was not pregnant at the time of vaccination. On 12Aug2021, the patient experienced hives, itchiness, big bumps and sore arm.  The patient underwent lab tests and procedures which included on 13Aug2021, SARS-COV-2 test, nasal swab: found negative. No treatment was given in response to the events. The outcome of the events was not recovered.
Lymphedema after second dose; Arm hung down 12 to 18 inches; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date at dose 2, single for covid-19 immunisation. Medical history was not reported. Concomitant medication included Lasix. Patient previously received first dose of BNT162B2 on an unspecified date at dose 1, single for COVID-19 immunization. On an unspecified date the patient experienced lymphedema after second dose, arm hung down 12 to 18 inches. Stated reporter was a consumer that received paperwork for an adverse event she had after her second dose of Pfizer Covid-19 Vaccine. Reporter had a question about the form. It was 5 to 7 days after her second dose, she developed lymphedema and they had to increase her Lasix. She has questions about the paperwork she received. She also said she had to go through Occupational Therapy because of this. While reporting on herself, reporter stated that when she signed in for Physical Therapy, the girl told her that about 30 percent of her patients were all from the second Covid vaccine and it all happened within the same time frame as the callers (within 5-7 days after the second COVID Vaccine). All of these people had lymphedema, and another thing they had in common was that they all had radiation treatment for cancer. She is just wondering if Pfizer's studies included any people who had radiation treatments because it seems like the 30% in the physical therapy class that had the Pfizer vaccine all had radiation. Reporter stated that one lady's arm hung down 12 to 18 inches and that was from the Covid vaccine. This report is in regard to the lady whose arm hung down 12 to 18 inches. Outcome of the events was unknown. Communication: No further information was provided or obtained. This is Report 3 of 3. MI filed on Report 1. Information about lot/batch number has been requested.  Follow up (20Aug2021): No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
REPORTED TO PHARMACIST BY PATIENT.  TOPICAL REDNESS, INFLAMMATION, TINGLING, PRICKLY FEELING ON LEFT ARM.  NO DIFFICULTY BREATHING.  PATIENT WILL NOTIFY HER DOCTOR AND  PHARMACIST WILL FOLLOW UP TO DETERMINE IF SECOND DOSE IS TO BEGIVEN
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported. On 26-NOV-2018, the patient was vaccinated with improperly stored ROTATEQ (lot # R002805, expiration date: 23-SEP-2019, strength, dose and frequency were unknown) orally for prophylaxis. No adverse effects were reported. The vaccines were exposed to temperature of 47 Fahrenheit (F) for 37 minutes. The temperature excursion was detected by a data logger. Previous temperature excursions were reported as 47 Fahrenheit (F) for 50 minutes. The case was one of the cases received from the same reporter. Sender's Comments: US-009507513-1901USA004786.
So I got the vaccine Monday night after work. Tuesday and Wednesday I ran a super high fever, body aches, lymphnode swelling on that side. No big deal . Well Thursday morning I woke up with a rash on both of my legs and my legs swollen like tree trunks. It?s a petechial rash. I called the pharmacist told to take Benadryl and Zyrtec since Friday. So I went to the doctors last night since I still have this rash and it hasn?t gotten any better with Benadryl and Zyrtec.  I got blood work done today. And I have  to get an arterial and venous Doppler done on Wednesday next week. They are concerned I may have blood clots since my legs are so swollen with a petechial rash. They are also giving me steroid tapper.
Information has been received from a certified medical assistant via a field representative referring to a female patient of unknown age. The patient was not pregnant. Information about medical history, concurrent condition and concomitant medication was not reported. On an unknown date the patient was vaccinated with GARDASIL or GARDASIL 9 (strength, dosage, frequency, series and route unspecified). The patient's mother reported that prior to the GARDASIL or GARDASIL 9, the patient's menstrual cycle was every four weeks. After vaccination the patient's menstrual cycle was every 2 weeks on an unspecified date in 2015 (reported as "now"). The patient sought medical attention via calling the reporter. The outcome of the event was unknown. Additional information has been requested.
Received vaccines on 3/13/01. Mother states child broke out with a couple of bumps under left eye, a couple of hours, post vax. Bumps went away that night. States child felt like she had a fever but never checked temperature. Mother states she gave the child Advil. States 3 days, post vax, child broke out with a fine rash over her stomach. Now rash has spread to all extremities. Temperature today is 97.8F with (maculopapular rash). Mother was advised to see PMD. Spoke with mother and called MD's office and was told that rash was from MMR and would clear up in about a week.
Patient given expired Pfizer Covid Vaccination 5 days past expiration date .  No adverse reaction reported, No treatments given.
Cellulitis NOS on 2013-10-04, Ot serum react d/t vacc on 2013-10-14.
20 minutes after vaccination, complained of tingling of the side of the tongue and mild throat swelling Pt was seen in ED, given pepcid and loratadine, and discharged home
Fever, chills: lasted about 24 hours   fatigue slight nausea: lasted about 48 hours  Treatment was rest and electrolyte drinks
Subcutaneous Injection; lump at injection site; A spontaneous report was received from a nurse concerning a 65-year old female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) via subcutaneous injection and experienced lump at injection site.   No relevant medical history and concomitant medications were reported.   On 20-Jan-2021, prior to the onset of the events, the patient received a dose of mRNA-1273 (lot number 032L20A) subcutaneously for prophylaxis of COVID-19 infection.  On 20-Jan-2021, the patient developed a lump at the injection site when vaccine was given to her subcutaneously. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not reported.  The event subcutaneous injection was considered to be resolved on 20-Jan-2021. The outcome of event lump at injection site was unknown.; Reporter's Comments: This report refers to a case of incorrect route of product administration  for mRNA-1273, lot #: 032L20A.  There were no reported AEs associated with this case of incorrect route of product administration.
Left shoulder pain the day following injection that has persisted for 2 months.  Also had flu shot administered in same arm at the same time as Arexy, however has had flu shot many times in the past.
This spontaneous report has been received from a registered nurse, concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not provided. On 21-SEP-2018 the patient was vaccinated with improperly stored dose of M-M-R II lot # reported as N024150 with expiration date 24-AUG-2019 (dose, frequency and route were not provided) for prophylaxis which was reconstituted with a properly stored of sterile diluent. No adverse effects reported. The vaccine was stored at a temperature of 47 Fahrenheit degree to 77 Fahrenheit degrees with a time frame of 1 hour and 10 minutes and previous temperature excursion of 47 Fahrenheit degree to 77 Fahrenheit degrees for 1 hour and 27 minutes and 47 Fahrenheit degree to 77 Fahrenheit degrees for 1 hour and 5 minutes. Digital Data logger was involved. This is one of eight reports received from the same reporter. Sender's Comments: US-009507513-1809USA013685: US-009507513-1809USA013686: US-009507513-1809USA013687: US-009507513-1809USA013684: US-009507513-1809USA012930: US-009507513-1809USA013682: US-009507513-1809USA013683.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2007, a healthcare provider at a family practice administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2014, the patient was treated by a healthcare provider at the family practice for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is considered to be not recovered. Additional information has been requested.
Autopsy confirmed myocardial event and fluid around her heart and lungs; Autopsy confirmed myocardial event and fluid around her heart and lungs; Prior symptoms included fatigue; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 19-year-old female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), for COVID-19 Immunization; Bnt162b2 (Dose 2), for Covid-19 immunization. The following information was reported: CARDIOMYOPATHY (death), HYPERVOLAEMIA (death), outcome "fatal" and all described as "Autopsy confirmed myocardial event and fluid around her heart and lungs"; FATIGUE (non-serious), outcome "unknown", described as "Prior symptoms included fatigue". The patient date of death was 09Jul2022. Reported cause of death: "Autopsy confirmed myocardial event and fluid around her heart and lungs". The autopsy revealed "myocardial event" (cardiomyopathy); "fluid around her heart and lungs" (hypervolaemia).  Clinical course: Patient died in her sleep 09Jul2022. Autopsy confirmed myocardial event and fluid around her heart and lungs. Prior symptoms included fatigue. Mother mentioned cause of death 13Jul2022 and that daughter was vaccinated, primary series and booster. Patient passed away in (withheld) and was taken to coroner on 09Jul2022. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: Autopsy confirmed myocardial event and fluid around her heart and lungs; Autopsy confirmed myocardial event and fluid around her heart and lungs; Autopsy-determined Cause(s) of Death: myocardial event; fluid around her heart and lungs
I had a massive headache down the back of my head it felt like it was going to explode, I had Fever, Chilling, Body Aches. I treated myself with Nyquil, Dayquil, Mucinex, Chewable Elderberries Zinc and Vitamin C.
Pt. anxious and weepy. After receiving vaccination @ 3:35PM walked to chair, sat down and started talking to his mother. He then became still for several seconds with head down as he was sitting up. Mother and LPN talked with patient. He responded took orange juice and was then alert and communicating. Entire event lasted approximately 15-20 seconds.
Pt developed fever to 102 F yesterday evening with chills and fatigue. She states the fatigue started a day after getting her COVID booster this past Saturday and progressed as the days went on. She states that her drains have not been putting out any more than usual which is around 150 cc day. She also endorses no change in consistency or color of drainage. She states it has been serosanguineous the whole time. Denies any skin changes to the thigh or any new pain. She denies any chest pain, SOB, or dysuria. She has not been taking abx with the drains due to her hx of C diff infection requiring fecal transplant. In the clinic she had fever to 102 but was given tylenol and a dose of cefepime and vancomycin which then brought the fever down. She has been afebrile since then and HDS. She also states that her fatigue has significantly improved overnight and does not have any more chills.